| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.19 | 6e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.87 | 0.0003 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |